NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/09/2024
Back to search
Official data from USPTO
HPLE-LM AMINO ACIDS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
HPLE-LM AMINO ACIDS
ST13
US500000090218798Class
1, 42
Filing
90218798
Registration
7443872
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
07/09/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 42
Filing date
09/28/2020
Registration date
07/09/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/09/2024
Last transaction
07/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-10-00
First use in commerce
2021-10-00
Drawing code
4
Owner type
03
Owner location
Waukegan, IL
Examiner
BUSH, KAREN K
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pfanstiehl, Inc.
Representatives
Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and biochemicals for use in the formulationdevelopment and manufacture of pharmaceuticalsbiopharmaceuticalsvaccinesfinished drug productsparenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in developmentformulation and manufacture of pharmaceuticalsbiopharmaceuticalsvaccinesinjectable formulationspharmaceutical intermediaries and drug formulations; chemicalsbiochemicalsstabilizerscatalystsenzymesformulation ingredientsadditivesdrug delivery molecules and carriersbuffersall for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticalsbiopharmaceuticalsvaccinesfinished drug products; formulation ingredientsadditivesdrug delivery moleculescarriersbuffersall for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
Class 42
Biochemical research and development; Chemicalbiochemicalbiological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/09/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/01/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/01/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/29/2024
IUAF
USE AMENDMENT FILED
05/23/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/23/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2023
EX5G
SOU EXTENSION 5 GRANTED
12/01/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/01/2023
EXT5
SOU EXTENSION 5 FILED
11/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/24/2023
EX4G
SOU EXTENSION 4 GRANTED
05/22/2023
EXT4
SOU EXTENSION 4 FILED
05/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/24/2022
EX3G
SOU EXTENSION 3 GRANTED
11/22/2022
EXT3
SOU EXTENSION 3 FILED
11/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/21/2022
EX2G
SOU EXTENSION 2 GRANTED
05/19/2022
EXT2
SOU EXTENSION 2 FILED
05/19/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/19/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/24/2021
EX1G
SOU EXTENSION 1 GRANTED
11/22/2021
EXT1
SOU EXTENSION 1 FILED
11/22/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/22/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/25/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/30/2021
PUBO
PUBLISHED FOR OPPOSITION
03/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/24/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/24/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/24/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/24/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/24/2021
DOCK
ASSIGNED TO EXAMINER
02/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2020
NWAP
NEW APPLICATION ENTERED
10/01/2020
Continuous trademark protection
Get notified about every new filing that threatens HPLE-LM AMINO ACIDS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.